A detailed history of Ifp Advisors, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ifp Advisors, Inc holds 31,964 shares of BMY stock, worth $1.83 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
31,964
Previous 28,418 12.48%
Holding current value
$1.83 Million
Previous $1.54 Million 13.89%
% of portfolio
0.05%
Previous 0.07%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$40.25 - $52.99 $142,726 - $187,902
3,546 Added 12.48%
31,964 $1.33 Million
Q1 2024

Jul 30, 2024

SELL
$47.98 - $54.4 $102,197 - $115,872
-2,130 Reduced 6.97%
28,418 $1.54 Million
Q4 2023

Jan 09, 2024

SELL
$48.48 - $57.85 $59,048 - $70,461
-1,218 Reduced 3.83%
30,548 $1.57 Million
Q3 2023

Oct 12, 2023

BUY
$57.89 - $64.73 $319,147 - $356,856
5,513 Added 21.0%
31,766 $1.84 Million
Q2 2023

Aug 04, 2023

BUY
$63.71 - $70.74 $9,046 - $10,045
142 Added 0.54%
26,253 $1.68 Million
Q1 2023

Apr 18, 2023

SELL
$65.71 - $74.53 $1.94 Million - $2.2 Million
-29,518 Reduced 53.06%
26,111 $1.81 Million
Q4 2022

Feb 07, 2023

BUY
$68.48 - $81.09 $65,466 - $77,522
956 Added 1.75%
55,629 $3.02 Million
Q3 2022

Nov 08, 2022

BUY
$0.13 - $76.84 $353 - $208,851
2,718 Added 5.23%
54,673 $2.99 Million
Q2 2022

Sep 06, 2022

BUY
$72.62 - $79.98 $3.77 Million - $4.16 Million
51,955 New
51,955 $2.83 Million
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $3.77 Million - $4.16 Million
-51,955 Closed
0 $0
Q1 2022

Sep 06, 2022

BUY
$61.48 - $73.72 $935,295 - $1.12 Million
15,213 Added 41.4%
51,955 $3.79 Million
Q1 2022

Aug 08, 2022

BUY
$61.48 - $73.72 $129,661 - $155,475
2,109 Added 6.09%
36,742 $2.68 Million
Q4 2021

Jan 12, 2022

SELL
$53.63 - $62.52 $2.71 Million - $3.15 Million
-50,457 Reduced 59.3%
34,633 $2.16 Million
Q3 2021

Oct 06, 2021

SELL
$59.17 - $69.31 $32,721 - $38,328
-553 Reduced 0.65%
85,090 $5.04 Million
Q2 2021

Jul 13, 2021

BUY
$61.91 - $67.42 $64,076 - $69,779
1,035 Added 1.22%
85,643 $5.71 Million
Q1 2021

Apr 30, 2021

SELL
$59.34 - $66.74 $5,755 - $6,473
-97 Reduced 0.11%
84,608 $5.33 Million
Q4 2020

Jan 25, 2021

BUY
$57.74 - $65.43 $739,938 - $838,485
12,815 Added 17.83%
84,705 $5.24 Million
Q3 2020

Oct 29, 2020

BUY
$57.43 - $63.64 $112,849 - $125,052
1,965 Added 2.81%
71,890 $4.32 Million
Q2 2020

Aug 05, 2020

BUY
$54.82 - $64.09 $269,769 - $315,386
4,921 Added 7.57%
69,925 $4.04 Million
Q1 2020

May 12, 2020

BUY
$46.4 - $67.43 $941,409 - $1.37 Million
20,289 Added 45.37%
65,004 $3.4 Million
Q4 2019

Jan 17, 2020

BUY
$49.21 - $64.19 $1.17 Million - $1.52 Million
23,744 Added 113.22%
44,715 $2.86 Million
Q3 2019

Nov 07, 2019

BUY
$42.77 - $50.71 $416,066 - $493,306
9,728 Added 86.52%
20,971 $1.06 Million
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $737,441 - $879,307
-16,344 Reduced 59.25%
11,243 $532,000
Q4 2018

Jan 23, 2019

SELL
$48.76 - $63.23 $795,958 - $1.03 Million
-16,324 Reduced 37.18%
27,587 $1.43 Million
Q3 2018

Oct 25, 2018

SELL
$55.19 - $62.25 $126,716 - $142,926
-2,296 Reduced 4.97%
43,911 $0
Q2 2018

Aug 07, 2018

SELL
$50.53 - $62.98 $526,825 - $656,629
-10,426 Reduced 18.41%
46,207 $0
Q1 2018

Jun 03, 2019

BUY
$59.92 - $68.98 $110,911 - $127,681
1,851 Added 3.38%
56,633 $3.47 Million
Q1 2018

May 09, 2018

SELL
$59.92 - $68.98 $110,911 - $127,681
-1,851 Reduced 3.27%
54,782 $0
Q4 2017

Jan 24, 2018

SELL
$59.94 - $65.35 $1.5 Million - $1.64 Million
-25,068 Reduced 30.68%
56,633 $0
Q3 2017

Oct 30, 2017

SELL
$55.23 - $63.74 $418,146 - $482,575
-7,571 Reduced 8.48%
81,701 $5.21 Million
Q2 2017

Jun 03, 2019

SELL
N/A
-3,651 Reduced 3.93%
89,272 $4.97 Million
Q1 2017

Jun 03, 2019

BUY
N/A
4,812 Added 5.46%
92,923 $5.05 Million
Q4 2016

Jun 03, 2019

BUY
N/A
5,001 Added 6.02%
88,111 $5.15 Million
Q2 2016

Jun 03, 2019

BUY
N/A
71,867 Added 639.22%
83,110 $6.11 Million
Q1 2016

Jun 03, 2019

BUY
N/A
11,243
11,243 $532,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.